Parametric Portfolio Associates’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.5M	Sell	116,069 -68,435	-37%	-$870K	﹤0.01%	2571
2021 Q4	$2.94M	Sell	184,504 -15,667	-8%	-$274K	﹤0.01%	2207
2021 Q3	$3.22M	Buy	200,171 +53,568	+37%	+$785K	﹤0.01%	2137
2021 Q2	$2.03M	Buy	146,603 +61,246	+72%	+$867K	﹤0.01%	2428
2021 Q1	$1.25M	Sell	85,357 -24,502	-22%	-$416K	﹤0.01%	3055
2020 Q4	$1.91M	Sell	109,859 -14,058	-11%	-$250K	﹤0.01%	2682
2020 Q3	$2.27M	Buy	123,917 +49,954	+68%	+$929K	﹤0.01%	2431
2020 Q2	$1.32M	Sell	73,963 -92,968	-56%	-$1.57M	﹤0.01%	2762
2020 Q1	$2.71M	Buy	166,931 +95,588	+134%	+$1.77M	﹤0.01%	2182
2019 Q4	$1.28M	Sell	71,343 -1,828	-2%	-$33.7K	﹤0.01%	2927
2019 Q3	$1.48M	Sell	73,171 -21,517	-23%	-$430K	﹤0.01%	2811
2019 Q2	$2.09M	Buy	+94,688	New	+$1.64M	﹤0.01%	2646
2018 Q3	–	Sell	-10,344	Closed	-$145K	–	3944
2018 Q2	$145K	Sell	10,344 -11,389	-52%	-$163K	﹤0.01%	3758
2018 Q1	$240K	Buy	21,733 +1,783	+9%	+$19.5K	﹤0.01%	3688
2017 Q4	$176K	Buy	+19,950	New	+$214K	﹤0.01%	3773